Agios Pharmaceuticals, Inc.

AGIONASDAQHealthcareBiotechnology

$36.85- (-)1Y −11.64%

As of Oct 26, 2026 close

Market cap: $2.19B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $22.24$46.00
Volume (live): -
Avg. volume (3M): 1.17M

Agios Pharmaceuticals, Inc. (AGIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Agios Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy

Based on 7 unique analysts

(14 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$45.20

+22.66% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest AGIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 21, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Oct 9, 2026	Luca Issi	RBC Capital	Maintains	Hold	$32.00
Oct 7, 2026	Gregory Renza	Truist	Maintains	Buy	$39.00 → $37.00 −2.00 (−5.1%)
Oct 6, 2026	Alec Stranahan	BofA Securities	Maintains	Buy	$50.00
Oct 2, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Sep 21, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$46.00 → $50.00 +4.00 (+8.7%)
Aug 11, 2026	Gregory Renza	Truist	Maintains	Buy	-
Aug 4, 2026	Marc Frahm	TD Cowen	Maintains	Buy	-
Jul 31, 2026	Samantha Semenkow	Citi	Maintains	Buy	$46.00 → $52.00 +6.00 (+13.0%)
Jul 31, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Jul 31, 2026	Luca Issi	RBC Capital	Maintains	Hold	$32.00
Jul 30, 2026	Emily Bodnar	HC Wainwright	Maintains	Buy	$52.00 → $55.00 +3.00 (+5.8%)
Jul 30, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$46.00
Jul 30, 2026	Luca Issi	RBC Capital	Maintains	Hold	$32.00

Zacks Equity Research

BuyInitiates Coverage

Oct 21

Luca Issi

RBC Capital

HoldMaintains

$32.00

Oct 9

Gregory Renza

Truist

BuyMaintains

$39.00 → $37.00

Oct 7

Alec Stranahan

BofA Securities

BuyMaintains

$50.00

Oct 6

Zacks Equity Research

BuyInitiates Coverage

Oct 2

Alec Stranahan

BofA Securities

BuyReiterates

$46.00 → $50.00

Sep 21

Gregory Renza

Truist

BuyMaintains

Aug 11

Marc Frahm

TD Cowen

BuyMaintains

Aug 4

Samantha Semenkow

Citi

BuyMaintains

$46.00 → $52.00

Jul 31

Zacks Equity Research

HoldInitiates Coverage

Jul 31

Luca Issi

RBC Capital

HoldMaintains

$32.00

Jul 31

Emily Bodnar

HC Wainwright

BuyMaintains

$52.00 → $55.00

Jul 30

Alec Stranahan

BofA Securities

BuyReiterates

$46.00

Jul 30

Luca Issi

RBC Capital

HoldMaintains

$32.00

Jul 30

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AGIO?

The analyst consensus rating for AGIO is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for AGIO?

The average 12-month price target for AGIO is $45.20, representing an upside of 22.7% from the Oct 26, 2026 close of $36.85.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.